Yes. The letter was signed by an executive director named Leigh Greiner, and her supervisor who called me was deputy Mark Sieben.
I think these matters actually are directly related to sovereignty in the sense of Canadians being able to exercise due control over the ways that pharmaceuticals are dispensed and knowledge about their effectiveness. First, on the one hand, that's internal. Second are the points I raised about the absence of a need to disclose funding provided to clinicians, universities and others, which is a distorting influence that signifies, to me, an external threat to Canada's sovereignty.